期刊文献+

CEA、AFP、CA199、CA153在肺癌诊断中的临床应用价值 被引量:9

Clinical value of CEA, AFP, CA199 and CA153 in the diagnosis of lung cancer
下载PDF
导出
摘要 目的分析癌胚抗原(carcinoembryonic antigen,CEA)、甲胎蛋白(alpha fetoprotein,AFP)、糖链抗原199(carbohydrate antigen 199,CA199)、CA153对肺癌的诊断价值。方法选取我院经影像学、病理证实肺癌患者70例(肺癌组)、肺部良性病变患者60例(肺部良性病变组)及健康体检人员65例(正常对照组),通过全自动电化学发光仪测定各组CEA、AFP、CA199及CA153水平,比较各组上述肿瘤标志物阳性率,并比较不同肿瘤标志物对肺癌诊断的灵敏度、特异性及准确度。结果肺癌组、肺部良性病变组及正常对照组间血清CEA、AFP、CA199、CA153检测结果比较,差异均具有统计学意义(P均<0.05);肺癌组血清CEA、AFP、CA199、CA153检测水平均明显高于肺部良性病变组与正常对照组,差异均有统计学意义(P均<0.01);肺部良性病变组CEA、AFP、CA153水平均明显高于正常对照组(P均<0.05),且差异均有统计学意义(P均<0.05)。不同组织分型肺癌组CEA、AFP、CA199、CA153比较差异均无统计学意义(P均>0.05)。肺癌组、肺部良性病变组及正常对照组间CEA、AFP、CA199、CA153阳性检出率比较,差异均有统计学意义(P均=0.000);肺癌组各肿瘤标志物阳性检出率均高于肺部良性病变组及正常对照组,且差异均有统计学意义(P均<0.05);肺部良性病变组与正常对照组间各肿瘤标志物阳性检出率差异均无统计学意义(P均<0.05)。4项肿瘤标志物单独检测诊断肺癌的灵敏度、准确度均较低,但特异性较高,均>95.00%,4项联合检测可提高诊断肺癌的灵敏度及准确度。结论 CEA、AFP、CA199、CA153对肺癌诊断有一定的价值,各肿瘤标志物联合检测,能有效提高肺癌诊断准确度。 Objective To analyze the value of carcinoembryonic antigen (CEA), alpha fetoprotein (AFP), carbohydrate antigen 199(CA199) and CA153 in the diagnosis of lung cancer. Methods 70 cases of patients with lung cancer confirmed by imaging and pathology , 60 cases of patients with lung benign lesions and 65 cases of healthy persons were selected as study subjects in our hospital and which were respectively di-vided into lung cancer group, benign lung group and normal group. The levels of CEA, AFP, CA199 and CA153 were measured by automatic electrochemical luminescence instrument. The positive rates of tumor markers mentioned above were compared among the groups. The sensitivity , specificity and accuracy of differ-ent tumor markers in diagnosis of lung cancer were compared. Results There were statistical significance in the differences of CEA, AFP, CA199 and CA153 levels among three groups (Pall〈0.05). The levels of CEA, AFP, CA199 and CA153 in cancer group were all higher than that of benign lung group and normal group, and the differences all had statistical significance (Pall〈0.01). The levels of CEA, AFP, CA153 in benign lung group were all higher than that of control group, and the differences all had statistical significance(Pall〈0.05). There was no statistical significance in the differences of CEA, AFP, CA199 and CA153 levels among different tissue typing groups(Pall〉0.05). There were statistical significance in the differences of positive rates of CEA, AFP, CA199 and CA153 among three groups (Pall=0.000). The positive rates of CEA, AFP, CA199 and CA153 in cancer group were all higher than that of control group and benign lung group , and the differences all had statistical significance(Pall〈0.05). There was no statistical significance in the differences of positive rates of all the index between begin lung group and control group (Pall〉0.05). The sensitivity and accuracy of 4 tu-mor markers in lung cancer diagnosis were all lower, but specificity were all higher, which were all higher than 95.00%, and combined detection could improve the sensitivity and accuracy. Conclusion CEA, AFP, CA199 and CA153 have certain value in the diagnosis of lung cancer , especially the combined detection of tu-mor markers can effectively improve the accuracy of diagnosis of lung cancer.
出处 《实用检验医师杂志》 2016年第2期75-78,共4页 Chinese Journal of Clinical Pathologist
关键词 肺癌 肿瘤标志物 阳性表达 诊断价值 Lung cancer Tumor marker Positive expression Diagnostic value
  • 相关文献

参考文献8

二级参考文献78

  • 1丁湘彧,张宝秋,张洁,王雪玉,尹颜军,荣长利,时广利.肺癌患者血清中肿瘤标志物检测的临床意义[J].中华临床医师杂志(电子版),2011,5(16):4646-4650. 被引量:35
  • 2梅同华,徐小杰.四项肿瘤标志物测定对癌性、结核性胸腔积液的鉴别诊断价值[J].重庆医科大学学报,2004,29(6):814-816. 被引量:11
  • 3刘晓芳,张沪生.联合检测血清肿瘤标志物对肺癌的诊断价值[J].首都医科大学学报,2005,26(4):464-466. 被引量:2
  • 4Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer [J].N Engl J Meal,2002,346(2) :92-98.
  • 5Barak V, Goike H, Panaretakis KW, et al. Clinical utility of eytokeratins as tumor markers [ J ]. Clin Biochem,2004,37 ( 7 ) : 529-540.
  • 6Muley T, Dienemann H, Ebert W. Increased CYFRA 21 - 1 and CEA levels are negative predictors of outcome in p-stage I NSCLC [ J ]. Anticancer Res,2003,23 (5b) :4085-4093.
  • 7罗玲,罗晓红,段朝晖.血清CEA、CA125、CYFRA21-1联合检测对肺癌的诊断价值[J].中国卫生检验杂志,2007,17(9):1655-1656. 被引量:5
  • 8Miedouge M, Rouzaud P, Salama G, et al. Evaluation of seven tumor markers in pleural fluid for the diagnosis of malignant effu- sions[J. Br J Cancer, 1999,81 (5) 1059-1065.
  • 9Lee JH,Chang JH. Diagnostic utility of serum and pleural fluid earcinoembyonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer [J]. Chest 2005,128(24) :2298-2303.
  • 10Liang QL, Shi HZ, Qin XJ, et al. Diagnostic accuracy of tumor markers for malignant pleural effusion:a meta-analysis[J. Tho- rax,2008,63(1) :35-41.

共引文献98

同被引文献112

引证文献9

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部